Fexofenadine HCl, an active metabolite of terfenadine, has demonstrated to be a nonsedating Histamine H1 receptor antagonist. Mechanistic studies have reported that high concentrations of this compound can inhibit Cox-1 activity while low concentrations of Fexofenadine HCl inhibits Cox-2 activity.